Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Camino Minerals Corporation Advancing high-grade copper and precious metal projects from discovery to production.	Canada	COR
Cantargia Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.	Sweden	CANTA
Captor Therapeutics S.A. Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.	Poland	CTX
Cardiff Oncology, Inc. Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.	United States of America	CRDF
Cardio Diagnostics Holdings, Inc. AI-powered epigenetic and genetic tests for early detection of heart disease risk.	United States of America	CDIO
Cardiol Therapeutics Inc. Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.	United States of America	CRDL
CareDx, Inc. Precision diagnostics and surveillance solutions for the organ transplant journey.	United States of America	CDNA
CAREERLINK CO.,LTD. Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.	Japan	6070
Caris Life Sciences, Inc. Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.	United States of America	CAI
Carna Biosciences, Inc. Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.	Japan	4572